Denmark vs Malawi: Access to anti-retroviral drugs, female
Denmark
91.0%
in 2023
Malawi
93.0%
in 2024
Denmark rank
25th
Malawi rank
22nd
Access to anti-retroviral drugs, female over time
- Denmark
- Malawi
How they compare
Malawi currently reports 93.0% against 91.0% in Denmark, a difference of 2.0%.
The two have swapped places 1 time across 24 shared years of data; in 2000 it was Denmark ahead.
Denmark ranks 25th and Malawi ranks 22nd of 141 countries.
Across the 3 decades both report, Denmark averaged higher in 2 and Malawi in 1.
Head to head by decade
| Decade | Denmark | Malawi | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 51.0% | 7.1% | 43.9% | Denmark |
| 2010s | 77.9% | 62.4% | 15.5% | Denmark |
| 2020s | 88.0% | 91.2% | 3.2% | Malawi |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, female, Denmark or Malawi?
- Malawi, at 93.0% against 91.0% in Denmark as of 2024.
- What is the difference in access to anti-retroviral drugs, female between Denmark and Malawi?
- 2.0%, with Malawi ahead.
- How many years of comparable data are there for Denmark and Malawi?
- 24 years are reported by both, from 2000 to 2023.
- How do Denmark and Malawi rank globally for access to anti-retroviral drugs, female?
- Denmark ranks 25th and Malawi ranks 22nd of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, female (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.